Humana Inc. $HUM Stake Reduced by Crake Asset Management LLP

Crake Asset Management LLP reduced its stake in shares of Humana Inc. (NYSE:HUM) by 56.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,310 shares of the insurance provider’s stock after selling 43,640 shares during the quarter. Humana comprises approximately 0.3% of Crake Asset Management LLP’s holdings, making the stock its 15th largest position. Crake Asset Management LLP’s holdings in Humana were worth $8,788,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Montag A & Associates Inc. boosted its position in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the period. CoreCap Advisors LLC boosted its position in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new position in Humana during the 4th quarter worth $27,000. Rosenberg Matthew Hamilton boosted its position in Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares during the period. Finally, Larson Financial Group LLC boosted its position in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after acquiring an additional 81 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the subject of a number of analyst reports. Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a research report on Wednesday, May 20th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research report on Tuesday, April 21st. The Goldman Sachs Group boosted their price target on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research report on Thursday, April 30th. Morgan Stanley boosted their price target on Humana from $146.00 to $217.00 and gave the stock an “underweight” rating in a research report on Friday, May 15th. Finally, Mizuho upped their price objective on Humana from $290.00 to $335.00 and gave the company an “outperform” rating in a report on Wednesday, May 20th. Nine analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $270.48.

Humana Trading Down 0.9%

Shares of Humana stock opened at $305.97 on Friday. The business has a fifty day simple moving average of $231.96 and a 200-day simple moving average of $229.04. The firm has a market cap of $36.73 billion, a price-to-earnings ratio of 32.72, a price-to-earnings-growth ratio of 2.21 and a beta of 0.68. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $315.66.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts forecast that Humana Inc. will post 9.01 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana’s payout ratio is 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.